This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Hiroshima Industrial Promotion Organization, Japan Science and Technology Agency. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2007
Title: Chihiro Yamasaki: Innovator in Hepatocyte Research
Introduction
Chihiro Yamasaki is a notable inventor based in Hiroshima, Japan. He has made significant contributions to the field of hepatocyte research, particularly through his innovative patent related to human liver cells. His work has implications for medical science and therapeutic applications.
Latest Patents
Chihiro Yamasaki holds a patent titled "Antibody recognizing proliferative human liver cells, proliferative human liver cells and functional human liver cells." This invention provides a monoclonal antibody that specifically recognizes proliferative human hepatocytes. It also includes a method for isolating these cells using the antibody and a method for inducing differentiation into functional human hepatocytes. Furthermore, the invention encompasses the proliferative and functional human hepatocytes obtained through these methods, as well as a cell kit and a hybrid artificial liver comprising those hepatocytes. He has 1 patent to his name.
Career Highlights
Throughout his career, Chihiro Yamasaki has worked with esteemed organizations such as the Japan Science and Technology Agency and the Hiroshima Industrial Promotion Organization. His roles in these institutions have allowed him to advance his research and contribute to the scientific community.
Collaborations
Chihiro has collaborated with notable colleagues, including Katsutoshi Yoshizato and Chise Mukaidani. Their joint efforts have furthered the understanding and application of hepatocyte research.
Conclusion
Chihiro Yamasaki's innovative work in the field of hepatocyte research highlights his contributions to medical science. His patent on recognizing and isolating human liver cells showcases the potential for advancements in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile